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 Abstract 
 Aim: To study the course and prognostic implications of orthostatic hypotension (OH) in 
older individuals with mild-to-moderate dementia.  Methods: Referrals to outpatient clinics 
specialising in old age psychiatry and geriatric medicine in the counties of Rogaland and 
Hordaland in western Norway with a first-time diagnosis of mild dementia were consecutive-
ly asked for inclusion. A total of 211 participants underwent a comprehensive baseline assess-
ment with annual follow-ups. Patients with OH at both baseline and the 1-year follow-up were 
classified as having persistent OH. Outcome measures were the Mini-Mental State Examina-
tion (MMSE), the Clinical Dementia Rating sum of boxes (CDR-SB), and time to death.  Results: 
From baseline to the 4-year follow-up, 30–45% of the participants had OH at each follow-up. 
In multivariable analysis, persistent OH was not significantly associated with either the longi-
tudinal course of MMSE or CDR-SB scores or survival.  Conclusions: OH was moderately prev-
alent over 4 years in older individuals with mild dementia, and persistent OH did not predict 
either cognitive or functional decline or survival.  © 2014 S. Karger AG, Basel 
 Introduction 
 Orthostatic hypotension (OH)  [1, 2] , corresponding to the syndrome known as ‘classical 
OH’  [3] , is commonly diagnosed in older individuals  [4] , including those with dementia  [5–7] . 
Generally, as well as in a single older patient, OH may have several causes, including age-
related changes in the cardiovascular and autonomic nervous systems  [8] , autonomic 
dysfunction (which is common in neurodegenerative dementias)  [9] , medication  [10] , and 
acute illness with a reduction in intravascular volume  [8] . OH is associated with falls  [11] , 
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coronary heart disease, and mortality  [12] . It also has been associated cross-sectionally with 
cognitive impairment in the elderly  [13, 14] .
 However, only few studies have explored the potential longitudinal implications of OH 
with regard to cognitive function in older individuals with mild dementia. Viramo et al.  [15] 
found no longitudinal association between OH and cognition over a period of 2.5 years; 
cognitive decline was predicted only by old age and a low level of formal education. Likewise, 
not much is known with respect to the potential implications of OH for activities of daily living 
(ADL), although a previous cross-sectional study found that higher autonomic symptom 
scores and postural dizziness in non-Alzheimer’s dementias were associated with poorer 
outcomes in ADL  [16] . Concerning the potential impact of OH on survival in dementia, Stuben-
dorff et al.  [17] recently found that patients with dementia with Lewy bodies (DLB) and 
Parkinson’s disease with dementia (PDD) with persistent OH over a period of up to 6 months 
had a significantly shorter survival than those without persistent OH.
 OH is potentially treatable  [18, 19] , meaning that its possibly negative impact on cognitive 
function and ADL might be alleviated. Notably, in the majority of dementia patients with OH, 
classical symptoms such as dizziness or unsteadiness seem to be absent  [20] . 
 The reproducibility of OH on repeated measurements has been studied in various popu-
lations  [21–25] , with inconsistent results  [26] . It has not, to our knowledge, been established 
whether, and to what extent, OH is persistent over the longer term in older individuals with 
dementia. In a previous study, we reported the cross-sectional prevalence of OH in individuals 
with mild dementia  [7] . Here, we wanted to study the longitudinal course of OH in the stages 
of mild-to-moderate dementia and to investigate the hypothesis that patients with persistent 
OH have a more rapid cognitive and functional decline as well as a shorter survival than those 
without OH.
 Subjects and Methods 
 Ethics Statement 
 The study was approved by the Regional Committee for Medical and Health Research 
Ethics (REC West) and the Norwegian authorities for the collection of medical data. Each 
patient provided written consent to participate in the study after the procedures had been 
explained in detail to him/her and a caregiver, usually the spouse or an offspring.
 Subjects 
 From March 2005 to April 2007, all referrals to the 5 outpatient clinics specialising in old 
age psychiatry and geriatric medicine in the counties of Rogaland (Stavanger and Haugesund) 
and Hordaland (Bergen) in western Norway were screened for patients with a first-time diag-
nosis of mild dementia (according to the DSM-IV  [27] ) having a Mini-Mental State Exami-
nation (MMSE)  [28] score of 20 or more (upper limit: 30). Additionally, the 3 neurology 
outpatient clinics in the same area were contacted, and they agreed to refer new cases with 
mild dementia to one of the participating centres. The patients and caregivers were first seen 
by a study clinician, who performed a structured clinical interview. The comprehensive 
assessment procedure included a detailed history, using a semi-structured interview, a 
clinical evaluation (including physical, psychiatric, neurological, and neuropsychological 
examinations), and routine blood tests.
 Procedures 
 The patients were followed up annually with the same assessment battery for the first 2 
years, thereafter with a simplified test battery.
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 Dementia Diagnosis 
 Diagnoses were made after a detailed evaluation, as previously described  [29] , including 
the use of standardised clinical assessments of psychiatric symptoms, parkinsonism, and 
cognitive fluctuations as well as brain magnetic resonance imaging (MRI)  [30] and blood 
tests. The diagnoses of Alzheimer’s disease (AD), DLB, PDD, and vascular dementia (VaD) 
were made according to consensus criteria  [31–34] , and those of alcoholic dementia and fron-
totemporal dementia (FTD) according to the DSM-IV criteria and the Lund-Manchester 
criteria  [35] , respectively. Patients with acute delirium or terminal illness, those recently 
diagnosed with a major somatic disease, and those with previous bipolar or psychotic disorder 
were excluded from the study. In the present study, the patients having DLB and those having 
PDD were combined into one group (Lewy body dementia, LBD) because these conditions 
have several biological and clinical similarities  [32, 36] .
 Clinical Assessment 
 The MMSE was used as a measure of cognitive function. The Clinical Dementia Rating sum 
of boxes  [37] (CDR-SB) was employed as a composite measure of cognitive and general 
function  [38, 39] . For the assessment of physical comorbidity, we employed the Cumulative 
Illness Rating Scale (CIRS). This scale measures the chronic medical illness burden while also 
taking into account the severity of a chronic disease. It was scored by an experienced geria-
trician in accordance with the guidelines  [40] . Depression was assessed using the Mont-
gomery-Åsberg Depression Rating Scale (MADRS)  [41, 42] .
 MR images were rated visually for the severity of white matter hyperintensities (WMH), 
using the Scheltens scale  [43] , by an experienced rater blinded to the clinical data. For further 
details, see Soennesyn et al.  [30] . In the present study, we used the Scheltens total WMH score 
only. For more details on the selection, diagnostic, and assessment procedures, see Aarsland 
et al.  [29] .
 Survival and Mortality 
 We registered all deaths from study inclusion until October 1, 2012.
 Blood Pressure Measurements and Definitions of OH 
 Blood pressures were measured using an analogue sphygmomanometer, once with the 
subject in the supine (n = 123) or sitting position (n = 83; n = 5 unknown whether supine or 
sitting) and then once within 3 min after standing up. If more than 1 standing measurement 
had been made for a given subject (n = 14 at the 1-year follow-up; n = 1 at the 2-year follow-
up), the lowest systolic and diastolic blood pressure values were used for the diagnosis of
OH  [12] .
 OH was defined according to the consensus criteria  [1, 2] as a reduction in systolic blood 
pressure of at least 20 mm Hg, or in diastolic blood pressure of at least 10 mm Hg, within
3 min of standing. ‘OH+’ (‘persistent’ OH) was defined as having OH both at baseline and at 
the 1-year follow-up, and ‘OH–’ (‘never’ OH) as not having OH at either of these examinations. 
The assessments took place during normal office hours (i.e. 8 a.m. to 4 p.m.).
 Statistical Analyses 
 Statistical analyses were performed using IBM SPSS Statistics version 20 and R version 
2.15.2. The baseline characteristics are presented as quartiles (continuous variables) and 
proportions (dichotomous variables). The proportions of patients with OH at each assessment 
are presented with continuity-corrected 95% confidence intervals (95% CI; http://
vassarstats.net/). The clinical outcome measure scores (MMSE and CDR-SB) in those with 
and those without OH at each assessment were compared using independent-samples t tests.
D
ow
nl
oa
de
d 
by
: 
Un
ive
rs
ite
ts
bi
bl
io
te
ke
t
12
9.
17
7.
16
9.
18
 - 
10
/2
/2
01
4 
9:
32
:5
7 
AM
286Dement Geriatr Cogn Disord Extra 2014;4:283–296
 DOI: 10.1159/000363514 
E X T R A
 Soennesyn et al.: Persistence and Prognostic Implications of Orthostatic Hypotension 
in Older Individuals with Mild-to-Moderate Dementia 
www.karger.com/dee
© 2014 S. Karger AG, Basel
 The survival analysis was conducted with Kaplan-Meier plots and Cox proportional 
hazards modelling in SPSS. As explanatory variables, we used OH+ (yes/no) together with 
various combinations of potential confounders (see below). The presence of time-dependent 
effects of OH was tested by means of the TIME PROGRAM command.
 Analyses of the longitudinal outcomes were performed with generalised estimating 
equations (GEE) in SPSS, in which OH+ (yes/no), time, and the interaction between OH+ and 
time were entered as model effects, along with various combinations of potential confounders 
from baseline measurements: centre, age, sex, education (in years), smoking  [44] (ever/
never), AD versus other dementia, dementia medication (acetylcholinesterase inhibitor or 
memantine – yes/no), CIRS score, cardiovascular disease (history of stroke or coronary heart 
disease – yes/no), MADRS score, and MMSE or CDR-SB score (the one that was not the 
dependent variable). Four modelling schemes were tried: (1) no adjustment, in which only 
terms involving OH+ and/or time were included; (2) adjusting for age and sex; (3) adjusting 
for all available potential confounders, and (4) adjusting for the variables that were deemed 
important after a (manual) stepwise reduction of the model based on likelihood ratio tests 
(though keeping OH+, time, the interaction OH+/time, sex, and age in the model). All the 
results were based on a robust estimation of unstructured correlation matrices.
 As informative dropout due to death  [45, 46] was suspected in this study, we also ran 
analyses which were intended to deal with this issue. The function ‘joineR’ in R  [47] is based 
on a linear mixed model for the longitudinal outcome and a proportional hazards model for 
the survival outcome, which are linked through common random effects. The various models 
described above were fitted, allowing for various kinds of links between the random effects 
relating to the longitudinal outcome and the frailty relating to the survival outcome. The 
optimal structure of random effects for each combination of fixed effects was determined by 
 Table 1.  Baseline clinical characteristics of the patients with OH measurements at both baseline and the 
1-year follow-up and of those not having these two measurements
 OH measurements both at baseline
and 1-year follow-up
Missing data
(n = 211)
yes (n = 133)  no (n = 78)
Age, years 77.2 (71.0 – 82.0) 76.5 (70.0 – 80.6) 0
Women, n (%) 79 (59) 45 (58) 0
Education, years 9 (8 – 12) 8 (7 – 10) 7
MMSE score 24.0 (22.0 – 26.0) 23.0 (21.8 – 25.3) 2
CDR-SB score 4.5 (3.5 – 6.4) 5.5 (3.5 – 8.0) 16
AD, n (%) 91 (68) 47 (60) 0
DLB/PDD, n (%) 28 (21) 26 (33) 0
VaD, n (%) 8 (6) 3 (4) 0
Other dementias (FTD, Alc.), n (%) 6 (5) 2 (3) 0
MADRS total scorea 6 (3 – 13) 7 (4 – 11) 1
Using antidementia medications, n (%)b 52 (39) 26 (34) 2
Smoker (former/current), n (%) 61 (47) 34 (47) 8
CIRS scorec 6 (4 – 7) 6 (4 – 8) 3
Cardiovascular disease, n (%)d 41 (33) 25 (35) 14
 Values denote medians with IQR in parentheses unless specified otherwise. Alc. = Alcoholic dementia.
a Range: 0 – 60. b Acetylcholinesterase inhibitor or memantine. c Range: 0 (no impairment) to 52 (extremely 
severe impairment). d History of stroke or coronary heart disease.
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the Akaike information criterion  [48] . Normal-based confidence intervals and Wald χ 2 p 
values for fixed and random effects were estimated by non-parametric (resampling) boot-
strapping (200 bootstrap samples)  [49] . Since the purpose of these joint models was to 
improve on the results for the longitudinal outcomes ‘CDR-SB score’ and ‘MMSE score’, we 
limited the covariates for the survival outcome to just OH+ (yes/no), age, and sex.
 The treatment of missing data amounted to excluding from each analysis the subjects 
with missing observations of the relevant variables (available case analysis), assuming non-
informative missingness. The exception to this was the joint analyses, where the effects of 
dropouts due to death were accounted for implicitly in the models.
 Results 
 Of the 211 patients available at baseline, 133 had OH measurements at both baseline and 
the 1-year follow-up. Patients with these two OH measurements had a somewhat longer 
education and higher cognitive performance than those not having these two measurements 
( table 1 ). Otherwise, the groups did not differ substantially with respect to the relevant 
baseline characteristics.
 Of the 133 patients, between 21 and 44 were recruited from each of the 4 largest partic-
ipating centres, but only 4 patients were recruited from the smallest, fifth centre. There were 
91 patients with AD and 28 having LBD. With respect to the variables in  table 1 , these groups 
differed significantly in terms of sex (69 vs. 43% women, p = 0.021), MADRS score (5 vs. 12, 
p = 0.001), use of antidementia medications (51 vs. 18%, p = 0.004), and CIRS total score (5.0 
vs. 6.5, p = 0.003).
 A total of 94 of the 211 patients included at baseline did not complete the 4-year follow-
up. Of these, 67 died prior to the expected 4-year follow-up time. Of the remaining 27 patients, 
8 withdrew from the study, 1 moved, 6 were excluded for various reasons, and 12 missed the 
follow-up for unknown reasons.
 Course of OH 
 At each assessment, OH measurements were available for 75–86% of the participating 
patients. For the point prevalence and persistence of OH from the previous examination 
among those measured, see  table 2 . Among the 85 patients with OH measurements at baseline, 
the 1-year follow-up, and the 2-year follow-up, 32 ‘never’ had OH, 18 had OH once, 27 twice, 
and only 8 had OH at all 3 measurements.
 Table 2. Point prevalence and persistence of OH from the previous examination among the patients evaluated 
(baseline to 4-year follow-up)
Baseline 1-year
follow-up
2-year
follow-up
3-year
follow-up
4-year
follow-up
Point prevalence of OH 74/169 
(44; 36 – 52)
51/163 
(31; 24 – 39)
36/121 
(30; 22 – 39)
50/112 
(45; 35 – 54)
39/87 
(45; 34 – 56)
Persistence of OH – 29/58 
(50; 37 – 63)
15/34 
(44; 28 – 62)
14/24 
(58; 37 – 77)
14/28 
(50; 31 – 69)
Values denote numbers with percentages and 95% CI in parentheses.
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 Of the 133 patients who had complete data on OH measurements at both baseline and 
the 1-year follow-up, 29 were OH positive on both occasions and were thus classified as 
‘persistent OH’ (OH+), whereas 57 were OH negative on both occasions and were classified 
as ‘never OH’ (OH–;  fig. 1 ). There were no significant differences in mean non-standing systolic 
or diastolic blood pressure between those measured in the supine and those measured in the 
sitting position at baseline (data not shown). The general condition of the patients in these 
groups (OH+ and OH–) at baseline did not differ significantly [good general condition 
(compared with average or bad): 93 vs. 85%, p = 0.482], and the median CIRS total score was 
6.0 (potential maximum score: 52) in both groups (p = 0.491). There were no significant 
differences between the OH+ and the OH– group with respect to history of hypertension (55 
vs. 44%, p = 0.437), prevalence of diabetes mellitus type 1 or 2 (13 vs. 0%, p = 0.090), preva-
lence of kidney disease (median CIRS renal score 0 in both groups), use of at least 1 medi-
cation associated with OH (antianginals, antihypertensives, tricyclic antidepressants, parox-
etine, MAO inhibitors, dopamine agonists, diazepam, dipyridamole, phenothiazines, clozapine, 
quetiapine, olanzapine, or haloperidol; 59 vs. 54%, p = 0.831), use of antihypertensive medi-
cation (55 vs. 46%, p = 0.592), or Scheltens total WMH score (median score: 11.5 vs. 14.0,
p = 0.525). Baseline serum lipid values were available for only 3 of these patients.
 OH and Survival 
 As of October 1, 2012, a total of 14 patients out of 29 (48%) had died in the OH+ group, 
whereas 29 out of 57 (51%) had died in the OH– group. A Kaplan-Meier plot with separate 
survival curves for each OH group is shown in  figure 2 . As can be seen, the curves are very 
similar. The mean survival time in the OH– group was 5.7 years (95% CI: 5.2–6.3), and in the 
OH+ group 5.8 years (95% CI: 5.1–6.5); the corresponding median survival times were 6.8 
and 6.2 years. A Cox regression model showed no significant effect of OH status (unadjusted 
p = 0.999). Adjusted for age and sex (both contributing significantly to the model), the esti-
mated HR for OH+ versus OH– was 0.83 (95% CI: 0.44–1.57, p = 0.562). Adding other baseline 
variables to the model (smoking, CDR-SB score, MMSE score, CIRS score, cardiovascular 
 OH measurement
at baseline and -year
follow-up
(n = 78)
Not included in
longitudinal analyses:
OH once at baseline
or 1-year follow-up
(n = 47)
OH measurement both
at baseline and -year
follow-up
(n = 
Included (Q 
Included in longitudinal
analyses (n = 86):
‘Persistent’ OH (n = 29)
‘Never’ OH (n = 57)
 Fig. 1. OH classification flow 
chart. 
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disease, AD vs. non-AD dementia, or centre) did not change the results substantially; neither 
did OH status interact statistically significantly with time in the tested models.
 OH and Function 
 Cognitive and general function declined as expected, as was measured with the MMSE 
and the CDR-SB. At the 4-year follow-up, the median MMSE score was 15.0 (IQR: 10.0–22.8) 
and the median CDR-SB score 13.0 (IQR: 8.4–15.3) among those having two OH measure-
ments from baseline to the 1-year follow-up. The corresponding values for those without two 
OH measurements were 15.5 (IQR: 8.0–20.0) and 13.0 (IQR: 10.0–15.5). There were no signif-
icant differences between those with and those without OH regarding MMSE scores ( fig. 3 ) or 
CDR-SB scores ( fig. 4 ) at baseline or at any of the follow-up examinations (all t test p values 
 ≥ 0.093).
 In total, we had 349 observations of MMSE scores and 350 observations of CDR-SB
scores for the 86 patients who were classified as either OH+ or OH–. So-called spaghetti plots 
of these observations, with LOESS curves fitted to each group separately, are shown in
1.0
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 Fig. 2. Observed survival for the 
OH+ group (grey) and for the OH– 
group (black). 
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 Fig. 3. Box plot of MMSE scores 
from baseline (BL) to 4-year fol-
low-up (FU4). Light grey: patients 
with OH at each examination. 
Dark grey: patients without OH at 
each examination. 
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 Fig. 4. Box plot of CDR-SB scores 
from baseline (BL) to 4-year fol-
low-up (FU4). Light grey: patients 
with OH at each examination. 
Dark grey: patients without OH at 
each examination. 
 Fig. 5. Course of MMSE scores for 86 patients having either persistent OH (OH+) or never OH (OH–) at base-
line and the 1-year follow-up. Observed individual curves (light grey) as well as fitted LOESS curves for the 
mean responses for the OH– group (solid black line) and for the OH+ group (dashed black line). 
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 figures 5 and  6 , respectively. These plots seem to imply that OH status has little impact on the 
course of CDR-SB and MMSE scores, as the LOESS curves are very similar for the OH– and the 
OH+ groups. The differences are found mostly towards the end, where the data are increas-
ingly scarce. Using GEE modelling ( table 3 ), we found that there was indeed no evidence of a 
differential longitudinal development in CDR-SB scores according to OH status (p > 0.76 for 
the interaction effect in all models); furthermore, there was no evidence of a difference in 
scores at baseline (p > 0.42). With regard to MMSE scores ( table 4 ), some differences at 
baseline showed up in the adjusted estimates (models 3 and 4, p < 0.005); however, we found 
little evidence of a difference in the slopes of the curves (all p  ≥ 0.24).
 Using the package joineR, we fitted joint models in which the longitudinal and the survival 
outcomes were linked through common random effects. For CDR-SB scores ( table 3 ), the 
results from joint modelling were similar to the GEE results, with very small and solidly non-
significant interaction effects (OH+/time) and with estimated baseline differences always 
smaller than 0.5 (in favour of the OH+ group; not statistically significant, p  ≥ 0.35). For MMSE 
scores ( table 4 ), the evidence of a differential longitudinal development increased somewhat 
(p values from 0.17 to 0.22); however, the statistically significant differences at baseline 
disappeared (though still indicated with the lowest p value of 0.063).
15
10
5
0
0 500 1,000 1,500 2,000
CD
R-
SB
 s
co
re
Time since baseline (days)
 Fig. 6. Course of CDR-SB scores for 86 patients having either persistent OH (OH+) or never OH (OH–) at base-
line and the 1-year follow-up. Observed individual curves (light grey) as well as fitted LOESS curves for the 
mean responses for the OH– group (solid black line) and for the OH+ group (dashed black line). 
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 Discussion 
 This is one of a few studies exploring the longitudinal course and clinical predictive 
power of OH in older individuals with dementia. The point prevalence of OH was 44% at 
baseline and remained in the range of 30–45% during the study period. The persistence of 
OH from one year to the next was around 50%, although only about 10% of the patients had 
OH at 3 successive examinations. One might perhaps expect an increasing OH prevalence over 
time due to ageing and associated baroreflex impairments  [4, 50] . Such an increase was not 
observed, however. This could be due to individuals with OH having a higher mortality rate 
 [17] , thus keeping the prevalence relatively constant, or due to the moderate length of our 
follow-up period. An alternative explanation is, as indeed our findings suggest, that the prev-
 Table 3. GEE and joint models for the longitudinal course of CDR-SB scores
Persistent OH Time Interaction
β (95% CI) p β (95% CI) p β (95% CI) p
GEE
Model 1a –0.36 (–1.23 to 0.52) 0.423 1.70 (1.46 – 1.95) <0.001 0.07 (–0.36 to 0.49) 0.762
Model 2b –0.36 (–1.26 to 0.55) 0.442 1.71 (1.46 – 1.96) <0.001 0.05 (–0.37 to 0.47) 0.817
Model 3c –0.46 (–1.79 to 0.88) 0.505 1.71 (1.45 – 1.97) <0.001 0.05 (–0.38 to 0.48) 0.830
Model 4d –0.40 (–1.67 to 0.87) 0.535 1.72 (1.46 – 1.98) <0.001 –0.01 (–0.43 to 0.41) 0.956
Joint
Model 1a –0.43 (–1.60 to 0.59) 0.361 1.75 (1.42 – 2.04) <0.001 0.06 (–0.43 to 0.64) 0.670
Model 2b –0.43 (–1.48 to 0.55) 0.350 1.75 (1.46 – 2.03) <0.001 0.06 (–0.40 to 0.53) 0.778
Model 3c –0.27 (–2.36 to 1.52) 0.656 1.82 (1.48 – 2.14) <0.001 0.01 (–0.45 to 0.53) 0.870
Model 4d –0.35 (–1.97 to 1.14) 0.605 1.84 (1.48 – 2.16) <0.001 –0.04 (–0.53 to 0.53) 0.989
a ‘Unadjusted’ (n = 86). b Adjusted for age and sex (n = 86). c Adjusted for all candidate covariates (n = 78). 
d Adjusted for age, sex, centre, smoking, antidementia medication, cardiovascular disease, education, and 
MMSE score at baseline (n = 79).
 Table 4. GEE and joint models for the longitudinal course of MMSE scores
Persistent OH Time Interaction
β (95% CI) p β (95% CI) p β (95% CI) p
GEE
Model 1a –0.49 (–1.38 to 0.39) 0.274 –2.41 (–2.87 to –1.96) <0.001 0.36 (–0.45 to 1.17) 0.383
Model 2b –0.56 (–1.52 to 0.40) 0.254 –2.41 (–2.85 to –1.96) <0.001 0.37 (–0.44 to 1.17) 0.370
Model 3c –2.08 (–3.47 to –0.68) 0.004 –2.57 (–3.02 to –2.12) <0.001 0.46 (–0.31 to 1.22) 0.240
Model 4d –1.89 (–3.08 to –0.69) 0.002 –2.45 (–2.86 to –2.02) <0.001 0.34 (–0.41 to 1.09) 0.377
Joint
Model 1a –0.69 (–1.77 to 0.34) 0.181 –2.72 (–3.25 to –2.15) <0.001 0.55 (–0.36 to 1.46) 0.214
Model 2b –0.58 (–1.75 to 0.58) 0.313 –2.68 (–3.13 to –2.22) <0.001 0.53 (–0.35 to 1.45) 0.223
Model 3c –1.08 (–2.27 to 0.13) 0.063 –2.81 (–3.40 to –2.18) <0.001 0.72 (–0.28 to 1.67) 0.172
Model 4d –0.70 (–1.71 to 0.22) 0.117 –2.74 (–3.25 to –2.16) <0.001 0.60 (–0.38 to 1.58) 0.219
a ‘Unadjusted’ (n = 86). b Adjusted for age and sex (n = 86). c Adjusted for all candidate covariates (n = 76). 
d Adjusted for age, sex, centre, CDR-SB score (at baseline), and CIRS score (n = 82).
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alence of OH in dementia is rather constant, even as the dementing disease progresses. It is 
possible that OH is caused by changes occurring early in the disease course. However, this 
might differ between various types of dementia. Due to the incompleteness of the relevant 
data, and also the relatively few patients in the non-AD groups, we were not able to fully 
explore this question. The rather constant prevalence of OH conceivably also could be due to 
adjustments of medications potentially contributing to OH, in response to a diagnosis of OH, 
or for other reasons. The lack of relevant data precluded adjusting for this potential contrib-
uting factor. Dehydration, which may be a prevalent problem in nursing home residents  [51] , 
might possibly also have affected the observed prevalence of OH, as more of the patients 
became nursing home residents due to progression of their dementia. Nevertheless, no 
increase in OH prevalence was observed.
 In two cross-sectional studies including patients with mild and moderate dementia, point 
prevalence values similar to ours were found for OH  [6, 9] in the AD and VaD groups, but 
higher values in the LBD group, which also appeared to have a more prolonged period of OH. 
These studies employed a longer standing OH measurement period with more measurement 
points  [52] and more precise measurement devices than our study.
 Regarding the longitudinal functional implications of OH, our results, which are in line 
with those of a previous study  [15] , did not confirm the hypothesis that having persistent OH 
predicts a more rapid cognitive and functional decline in these patients, at least not with 
regard to function as measured with the CDR-SB. However, with respect to cognitive function 
as measured with the MMSE, there seems to be some weak evidence of an association with 
OH status. Notably, both MMSE scores and CDR-SB scores are rather unspecific outcome 
measures, and the employment of more specific and sensitive instruments might have 
produced different results. Still, with respect to the MMSE, a study of cognitive functions in 
patients with neurogenic OH found OH to be associated with impairment of global cognitive 
functioning as well as more specific tasks, mainly concerning executive functions  [53] . 
Furthermore, both of these instruments have been used to follow the course of AD, DLB, and 
VaD in previous studies  [54–56] . Although the neuropsychological profiles of AD and DLB are 
different  [57] , the longitudinal decline in MMSE scores has been shown to be equivalent  [55] .
 The course towards the end of the follow-up period of both the MMSE and the CDR-SB 
scores raises suspicion with regard to a ‘healthy survivor’ effect, which might possibly 
influence the results in the ‘persistent’ OH and the ‘never’ OH groups differently. An approach 
to account for biases because of informative dropout due to death is to model the longitudinal 
and the survival responses jointly  [45–47] . Even though there do not seem to be any substantial 
differences in mortality rates between the two groups, there may be differences as to  who 
died. In the joint models, we found significant link parameters, implying that there were 
latent associations between the longitudinal and the survival processes. Even so, these 
extended analyses did not change our conclusions. 
 In contrast to a previous study including patients with LBD only  [17] , we found no asso-
ciation between persistent OH and survival. Notably, our study differs from this study with 
respect to both the types of dementia involved and the definition of persistent OH.
 Our study has some limitations. These include the relative lack of standardisation of the 
OH measurements, with only 1 standing OH measurement in most cases within a period 
limited to 3 min, a sizeable proportion of OH measurements starting from the sitting instead 
of the supine position, and the lack of a predetermined preceding period of rest. Furthermore, 
manual sphygmomanometers were employed instead of more precise devices, and the clini-
cians performing the measurements did not receive any particular training in OH measurement 
prior to the study. These factors may have led to an underestimation of the prevalence of OH 
 [52, 58] .
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 A proportion of the patients had missing data at some assessments, which may have 
resulted in less precise estimates of OH prevalence. However, except for data missing due to 
death, these missing data were random, and thus there was probably no systematic selection 
bias, suggesting that these factors did not systematically influence the findings. Still, our 
results should be interpreted with some caution.
 We realise that the study may not have the statistical power needed for us to discover 
potential small prognostic correlates of OH, and that some of the models used may have been 
over-parameterised considering the sample size. The confidence intervals for the effects of 
OH on MMSE and CDR-SB scores are all quite wide, reflecting the limited amount of data on a 
subject of substantial complexity. For the MMSE, plausible values for yearly change for the 
OH+ group versus the OH– group range from about –0.4 to +1.5; for the CDR-SB, every value 
between –0.5 and +0.5 is plausible. The point estimates, however, were relatively consistent 
in all the models and point towards no clinically relevant effect of having persistent OH either 
on survival or on the baseline level or longitudinal course of CDR-SB scores. As stated above, 
with regard to the longitudinal course of MMSE scores, there seems to be some weak evidence 
of an association with OH status, but this clearly should be explored in a larger sample.
 The strengths of this study include its prospective design, the relatively large sample of 
participants recruited from various centres, the inclusion of all common dementia subtypes, 
its comprehensive evaluation programme, the availability of data on a number of established 
or potential prognostic factors, and the comparatively long follow-up period.
 In conclusion, OH was moderately prevalent and persistent over time in a sample of older 
individuals initially having mild dementia. Our results did not confirm the hypothesis that 
persistent OH would predict a more rapid cognitive and functional decline in these patients 
or shorter survival. However, being a rather common and potentially treatable condition, and 
due to its association with falls, OH should be actively looked for in patients with dementia. 
Future studies should include a larger sample and use more rigorous methods for OH 
measurement.
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